Compare BLNK & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLNK | CVRX |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.2M | 81.3M |
| IPO Year | 2008 | 2021 |
| Metric | BLNK | CVRX |
|---|---|---|
| Price | $0.46 | $1.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $1.63 | ★ $4.58 |
| AVG Volume (30 Days) | ★ 1.1M | 527.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.22 | 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $126,197,000.00 | $56,651,000.00 |
| Revenue This Year | N/A | $3.89 |
| Revenue Next Year | $13.70 | $12.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $0.45 | $1.35 |
| 52 Week High | $2.15 | $11.30 |
| Indicator | BLNK | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 22.46 |
| Support Level | N/A | N/A |
| Resistance Level | $0.62 | $3.19 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 2.74 | 5.30 |
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The Blink's principal line of products and services is its Blink EV charging networks, Blink EV charging equipment, and other EV-related services. The Blink Network is a proprietary, cloud-based system that operates, maintains, and manages Blink charging stations and handles the associated charging data, back-end operations, and payment processing. The Blink Network provides fleets, property owners, managers, parking companies, and state and municipal entities, among other types of commercial customers, with cloud-based services.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.